| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Red Light Holland Corp: Red Light Holland's psilocybin selected for UCSF study | 2 | Stockwatch | ||
| Do | Red Light Holland Corp.: Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers | 347 | Newsfile | Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and stabilization methods to an independently sponsored UCSF... ► Artikel lesen | |
| 25.05. | Red Light Holland Corp: Red Light expands NZ psilocybin supply partnership | 4 | Stockwatch | ||
| 25.05. | Red Light Holland Corp.: Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate | 442 | Newsfile | The expanded agreement adds Filament Health, a wholly owned subsidiary of Red Light Holland, as a supplying affiliate and introduces a GMP-compliant standardized microdose format of PEX010 supported... ► Artikel lesen | |
| 14.05. | Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research | 454 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 14, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is an Ontario based organization advancing innovation... ► Artikel lesen | |
| 14.05. | Red Light Holland Corp: Red Light Holland shareholders approve name change | 3 | Stockwatch | ||
| 13.05. | Red Light Holland Corp.: Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders | 526 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light Holland" or the "Company") is pleased to announce that shareholders... ► Artikel lesen | |
| 08.05. | Red Light Holland Corp.: Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property | 447 | Newsfile | Peer-reviewed results published yesterday (May 7, 2026) in JAMA Network Open demonstrate that a single dose of psilocybin meaningfully reduced cocaine use in adults with cocaine use disorder over... ► Artikel lesen | |
| RED LIGHT HOLLAND Aktie jetzt für 0€ handeln | |||||
| 07.05. | Red Light Holland Corp: Red Light expands PEX010 distribution in North America | 4 | Stockwatch | ||
| 07.05. | Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions | 444 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is an Ontario-based organization advancing innovation... ► Artikel lesen | |
| 05.05. | Red Light Holland Corp: Red Light plans rebranding, including name change | 3 | Stockwatch | ||
| 30.04. | Red Light Holland Corp: Red Light Holland closes Filament Health acquisition | 5 | Stockwatch | ||
| 30.04. | Red Light Holland Corp.: Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution | 436 | Newsfile | Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including... ► Artikel lesen | |
| 29.04. | Red Light Holland Corp: Red Light Holland receives court OK for Filament buy | 5 | Stockwatch | ||
| 29.04. | Red Light Holland Corp.: Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement | 366 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")... ► Artikel lesen | |
| 27.04. | Red Light Holland Corp: Red Light target Filament receives shareholder approval | 2 | Stockwatch | ||
| 27.04. | Red Light Holland Corp.: Red Light Holland Announces Filament Health Shareholder Approval of Acquisition | 373 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased... ► Artikel lesen | |
| 24.04. | Red Light Holland Corp: Red Light target talks PEX010 clinical supply shipments | 6 | Stockwatch | ||
| 24.04. | Red Light Holland Corp.: Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments | 432 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and... ► Artikel lesen | |
| 21.04. | Red Light Holland Corp: Red Light notes psychedelic policy shift for Kala Bio | 30 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 36,160 | +1,69 % | DAX-Check LIVE: Bayer, BMW, CTS Eventim, Deutsche Telekom und Siltronic im Fokus | Der deutsche Aktienmarkt hat am Donnerstag erneut den Rückwärtsgang eingelegt. Der DAX rang im Tagesverlauf mit der psychologisch wichtigen Marke von 25.000 Punkten und ging schließlich leicht im Minus... ► Artikel lesen | |
| NOVO NORDISK | 37,860 | -0,72 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| NOVARTIS | 129,04 | +1,32 % | Weekly Buzz: Koninklijke Philips, Kamada Win FDA Nod; Fulcrum Therapeutics Halts Pociredir; ResMed Closes Noctrix Deal; Novartis Paces In IgAN | NEW BRUNSWICK (dpa-AFX) - This week, the biotech sector saw a wave of regulatory approvals in the U.S., alongside study halts, strategic collaborations, acquisitions, deal closures, and encouraging... ► Artikel lesen | |
| AURORA CANNABIS | 2,900 | -4,48 % | Aurora Deepens its Impact for Veterans Across Canada | ||
| SANOFI | 77,33 | +0,85 % | JEFFERIES stuft SANOFI auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Sanofi mit einem Kursziel von 100 Euro auf "Buy" belassen. Bei den Franzosen gebe es trotz des Führungswechsels keinen... ► Artikel lesen | |
| GSK | 22,410 | +1,91 % | UBS stuft GSK auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für GSK mit einem Kursziel von 1940 Pence auf "Neutral" belassen. Die auf der Hepatologen-Konferenz präsentierten Daten zum... ► Artikel lesen | |
| CANOPY GROWTH | 0,880 | -2,05 % | Canopy Growth Corporation: Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition | Pablo's Revenge, Dante'z Inferno, and Frost'd Flakes launched under Tweed brand Up to five additional strains expected to follow in June 2026 Company targeting rapid growth in Germany's medical... ► Artikel lesen | |
| STADA ARZNEIMITTEL | - | - | Enzymatica AB: Quarterly report Q1/2026 - Enzymatica strengthens international position through STADA agreement | First quarter
Net sales amounted to SEK 11.4 million (12.3).
Operating result amounted to SEK -13.6.million (-18.0)
Earnings per share, before... ► Artikel lesen | |
| ELI LILLY | 982,20 | +1,35 % | Rheinland-Pfalz: Lilly & Boehringer: Was der Schock fürs Land bedeutet | ||
| TILRAY BRANDS | 4,265 | -4,59 % | Tilray Brands Inc (2): Tilray's Breckenridge rolls out rye whisky | ||
| TEVA | 29,800 | +0,34 % | Teva Pharmaceutical Industries Ltd: Teva Presents New Data on AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease Chorea | New real-world survey data reveal the daily impact of Huntington's disease (HD) chorea, with over 68% of patients reporting interference with social life or emotional wellbeing1 and up to 83% of caregivers... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 392,50 | +3,15 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on ALYFTREK at European Cystic Fibrosis Conference | - ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels... ► Artikel lesen | |
| ABBOTT LABORATORIES | 79,04 | +1,15 % | Anhebungen seit 49 Jahren: Diesen Dividendenkönig in spe sollten sich Anleger jetzt genauer anschauen! | © Foto: Alexas_Fotos - UnsplashDer Medizintechnikkonzern Medtronic ist auf dem besten Weg dazu, ein Dividendenkönig zu werden. Nach einer kräftigen Korrektur ist die Aktie einen Blick wert. Jeden Tag... ► Artikel lesen | |
| INNOCAN PHARMA | 2,000 | -0,99 % | InnoCan Pharma vor kritischer Marke: Was die wenigsten Anleger auf dem Schirm haben - Was ich konkret unternommen habe! | ||
| MPH HEALTH CARE | 26,600 | +0,76 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
05.06.2026 / 12:45 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen |